Acetoxy drug: Protein transacetylase catalyzed activation of human platelet nitric oxide synthase by polyphenolic peracetates-Reference-Cited by-同舟云学术

Acetoxy drug: Protein transacetylase catalyzed activation of human platelet nitric oxide synthase by polyphenolic peracetates

Published:2006-01 Issue:2 Volume:14 Page:575-583
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Khurana Pulkit,Kumari Ranju,Vohra Parag,Kumar Ajit,Seema ,Gupta Garima,Raj Hanumantharao G.,Dwarakanath Bilikere S.,Parmar Virinder S.,Saluja Daman,Bose Mridula,Vij Anjana,Chaudhary Nabo K.,Adhikari Jawahar S.,Tyagi Yogesh K.,Kohli Ekta

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference31 articles.

1. The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels

2. Activation of Endothelial Nitric-Oxide Synthase by Tumor Necrosis Factor-α: A Novel Pathway Involving Sequential Activation of Neutral Sphingomyelinase, Phosphatidylinositol-3′ kinase, and Akt

3. Endothelial Nitric Oxide Synthase Is Regulated by Tyrosine Phosphorylation and Interacts with Caveolin-1

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-modulation by 7, 8-diacetoxy-4-methylthiocoumarin in total body-irradiated mice: Implications for the mitigation of radiation-induced hematopoietic injury;Life Sciences;2022-12

2. Polyphenolic Acetates as Potential Therapeutics and Adjuvant in Radiotherapy of Cancer;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022

3. Polyphenolic Acetates as Potential Therapeutics and Adjuvant in Radiotherapy of Cancer;Handbook of Oxidative Stress in Cancer: Therapeutic Aspects;2022

4. Site-directed mutagenesis in the P-domain of calreticulin transacylase identifies Lys-207 as the active site residue;3 Biotech;2021-02-03

5. Developing polyphenolic acetates as radiation countermeasure agents: current status and future perspectives;Drug Discovery Today;2020-04